China confirmed a few new foreign investment openings earlier today, but did not add any liberalizations beyond those already signalled over the past few months.
China Market Intelligence
Four new policies under development may address a variety of lingering regulatory hurdles for foreign drug and device companies in China.
China’s new Cybersecurity Law goes into effect today, June 1, but with many implementation details undecided and companies uncertain about how to comply. In the meantime, Chinese regulators are responding in part to company concerns, even if the overall policy approach remains problematic.
A recently released draft regulation requires a 30-day public comment period for all rules and measures issued by agencies under the authority of the State Council, as well as provincial and local governments.
China released a second draft revision of its Standardization Law on May 19 that links standards to national security, which could limit the use of foreign products and services, and endanger intellectual property (IP